NCT04564079View on ClinicalTrials.gov

An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

July 18, 2023

Study Completion Date

November 21, 2023

Conditions
NSCLC
Trial Locations (6)

E1C 2Z3

Centre hospitalier universitaire Dr-Georges-L.-Dumont, Moncton

E1C 6Z8

The Moncton Hospital, Moncton

K1H 8L6

The Ottawa Hospital, Ottawa

M5G 2C1

Princess Margaret Cancer Centre, Toronto

H3T 1E2

Jewish General Hospital, Montreal

J1H 5H3

Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke

Sponsors

Lead Sponsor

Exactis Innovation
All Listed Sponsors
lead

Exactis Innovation

OTHER

NCT04564079 - An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network | Biotech Hunter | Biotech Hunter